share_log

Altamira Therapeutics | F-3: Registration statement for specified transactions by certain foreign private issuers

SEC announcement ·  Jun 1, 2023 16:35
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more